How has been the historical performance of Brawn Biotech?

Answer:The historical performance of Brawn Biotech shows a consolidated net profit of 0.19 crore for the year ending March 2023, with net sales reported at 0.48 crore. The company experienced an operating profit (PBDIT) of 0.24 crore, resulting in a profit before tax of 0.22 crore and a profit after tax margin of 39.58%. The earnings per share (EPS) stood at 0.39, with a diluted EPS of 0.38. The operating profit margin was recorded at 0.0%, while the gross profit margin was notably higher at 50.0%.

In terms of assets and liabilities, Brawn Biotech's total assets were 14.13 crore as of March 2024, slightly down from 14.37 crore in March 2023. The company's total liabilities also decreased from 14.37 crore to 14.13 crore during the same period. Shareholder's funds declined from 6.31 crore in March 2023 to 5.07 crore in March 2024, reflecting a decrease in total reserves from 3.31 crore to 2.06 crore. The book value per share adjusted to zero in March 2024, down from 21.03 in March 2023. The cash flow results indicate no cash inflow or outflow for the years reported, with a consistent lack of cash equivalents. Overall, Brawn Biotech has shown some profitability but also a decline in reserves and shareholder equity over the years.

Breakdown:
Brawn Biotech's financial performance for the year ending March 2023 indicates a consolidated net profit of 0.19 crore, with net sales at 0.48 crore. The operating profit (PBDIT) was 0.24 crore, leading to a profit before tax of 0.22 crore and a profit after tax margin of 39.58%. The earnings per share were 0.39, while the gross profit margin was 50.0%. In terms of balance sheet performance, total assets decreased from 14.37 crore in March 2023 to 14.13 crore in March 2024, with total liabilities following a similar trend. Shareholder's funds also saw a decline from 6.31 crore to 5.07 crore, alongside a drop in total reserves from 3.31 crore to 2.06 crore. The book value per share adjusted to zero in March 2024, reflecting a significant decrease from the previous year. Cash flow results showed no activity, indicating a stagnant cash position over the reported years.